User contributions

From WikiPathways

Search for contributions

 Show contributions of new accounts only
 IP Address or username: Namespace: all (Main) Talk User User talk WikiPathways WikiPathways talk Image Image talk MediaWiki MediaWiki talk Template Template talk Help Help talk Category Category talk Thread Thread talk Summary Summary talk Pw Old Pw Old Talk Pathway Pathway Talk Wishlist Wishlist Talk Portal Portal Talk

From year (and earlier): From month (and earlier): all January February March April May June July August September October November December

(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)

• 05:01, 12 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma‎ (Add more interactions)
• 04:50, 12 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma‎ (Add more interactions, nodes, refine arrangement)
• 04:35, 12 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma‎ (Add interactions, economize layout)
• 03:10, 12 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma‎ (Refine arrangement)
• 04:30, 11 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma‎ (Add more nodes, begin arranging)
• 02:51, 11 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma‎ (Refine PKA into labeled complexes)
• 02:35, 11 December 2024 Homo sapiens:Albuterol and budesonide therapy for asthma‎ (Refine alignment)
• 02:14, 11 December 2024 N Homo sapiens:Albuterol and budesonide therapy for asthma‎ (New pathway)
• 03:38, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation‎ (Ontology Term : 'disease pathway' added !)
• 03:26, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation‎ (Ontology Term : 'Sturge-Weber syndrome' added !)
• 03:09, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation‎ (Ontology Term : 'vascular disease' added !)
• 03:02, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation‎ (Ontology Term : 'endothelial cell' added !)
• 02:58, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation‎ (Label cell type: endothelial cell)
• 02:39, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation‎ (Add literature reference)
• 02:38, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation‎ (Identify phenotype nodes)
• 02:35, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation‎ (Color phenotype nodes, economize layout)
• 02:07, 10 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation‎ (Add identifiers for metabolite nodes)
• 23:51, 9 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation‎ (Add Ensembl IDs as gene identifiers)
• 13:20, 9 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation‎ (Add more nodes, interactions)
• 04:56, 9 December 2024 Homo sapiens:GNAQ p.R183Q drives capillary malformation‎ (Add more nodes, arrange)
• 19:37, 8 December 2024 N Homo sapiens:GNAQ p.R183Q drives capillary malformation‎ (New pathway)
• 16:36, 8 December 2024 Homo sapiens:Inhibition of GNAQ-regulated signaling in uveal melanoma‎ (Add DrugBank ID for darovasertib)
• 16:33, 8 December 2024 Homo sapiens:Inhibition of GNAQ-regulated signaling in uveal melanoma‎ (Economize layout)
• 16:29, 8 December 2024 Homo sapiens:Inhibition of GNAQ-regulated signaling in uveal melanoma‎ (Economize layout)
• 16:21, 8 December 2024 Homo sapiens:Inhibition of GNAQ-regulated signaling in uveal melanoma‎ (Modified description)
• 16:20, 8 December 2024 Homo sapiens:Inhibition of GNAQ-regulated signaling in uveal melanoma‎ (Modified title)
• 15:26, 8 December 2024 Homo sapiens:Serotonin and anxiety‎ (Use gene symbol, identify EEF2K)
• 15:17, 8 December 2024 Homo sapiens:Serotonin and anxiety‎ (Label cell type, refine font)
• 15:13, 8 December 2024 Homo sapiens:Serotonin and anxiety‎ (Refine layout)
• 15:11, 8 December 2024 Homo sapiens:Serotonin and anxiety‎ (Economize layout)
• 15:09, 8 December 2024 Homo sapiens:Serotonin and anxiety‎ (Economize layout)
• 15:02, 8 December 2024 Homo sapiens:Serotonin and anxiety‎ (Increase font size, for readability)
• 15:00, 8 December 2024 Homo sapiens:Serotonin and anxiety‎ (Economize layout, enrich disease nodes)
• 14:34, 8 December 2024 Homo sapiens:Serotonin HTR1 group and FOS pathway‎ (Fix graphics discrepancy between PathVisio and Kaavio / Pvjs)
• 13:18, 8 December 2024 Homo sapiens:Serotonin HTR1 group and FOS pathway‎ (Clear cache to update board dimensions)
• 13:16, 8 December 2024 Homo sapiens:Serotonin HTR1 group and FOS pathway‎ (Economize layout)
• 03:50, 8 December 2024 Homo sapiens:Serotonin HTR1 group and FOS pathway‎ (Refine legend)
• 03:47, 8 December 2024 Homo sapiens:Serotonin HTR1 group and FOS pathway‎ (Increase font size, for readability)
• 03:39, 8 December 2024 Homo sapiens:Serotonin HTR1 group and FOS pathway‎ (Refine legend)
• 03:33, 8 December 2024 Homo sapiens:Serotonin HTR1 group and FOS pathway‎ (Economize layout)
• 03:32, 8 December 2024 Homo sapiens:Serotonin HTR1 group and FOS pathway‎ (Economize layout)
• 19:53, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome‎ (Add note again)
• 19:52, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome‎ (Note searching found no adequate identifier for "Bempedoyl-COA")
• 19:50, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome‎ (Identify more nodes)
• 19:48, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome‎ (Ontology Term : 'atherosclerosis' added !)
• 19:48, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome‎ (Ontology Term : 'metabolic dysfunction-associated steatotic liver disease' added !)
• 19:47, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome‎ (Ontology Term : 'metabolic dysfunction-associated steatohepatitis' added !)
• 19:46, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome‎ (Ontology Term : 'diabetes mellitus' added !)
• 19:46, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome‎ (Ontology Term : 'hepatocyte' added !)
• 19:46, 7 December 2024 Homo sapiens:Bempedoic acid therapy in atherosclerosis and metabolic syndrome‎ (Ontology Term : 'drug pathway' added !)

(Latest | Earliest) View (newer 50) (older 50) (20 | 50 | 100 | 250 | 500)